Invitation to a conference call and audio broadcast for the Devyser Q4 2021 report



STOCKHOLM, Feb. 17, 2022 /PRNewswire/ — On Thursday, February 24 at 09:00 CET, Devyser Diagnostics AB will host a conference call and online presentation of its fourth quarter 2021 interim report (which will have been released earlier on 24and at 08:00 CET). The presentation will be in English.

The dial-in numbers for the conference call are:
Sweden: +46 8 56 64 26 95
USA: +1 63 19 13 14 22 (PIN: 59400926#)
Rest of the world: +44 33 33 00 92 63

The presentation will be webcast and accessible from the following web address:

Speakers: CEO Fredrik Alpsten, CFO Sabina Berlin and Founder and Deputy CEO Ulf Klangby

For more information please contact:

Fredrik Alpsten, CEO
Email: [email protected]
Tel: +46 706 673 106

Sabina Berlin, Chief Financial Officer
Email: [email protected]
Tel: +46 739 519 502

About Devyser Diagnostics AB (publ)

Devyser specializes in the development, manufacture and marketing of diagnostic kits. Products are sold to routine diagnostic laboratories in over 45 countries. The products are used for complex DNA tests in hereditary diseases, oncology and transplantation. The products are used to guide targeted cancer therapies, to enable a wide range of genetic testing, as well as in post-transplant follow-up. Devyser’s product development focuses on simplifying and streamlining complex testing processes to improve throughput, reduce hands-on time, and produce accurate and reliable results. Devyser was founded in 2004 and is based in Stockholm, Sweden.

Devyser shares are listed on the Nasdaq First North Growth Market (ticker: DVYSR). The company’s Certified Advisor is Redeye AB, email [email protected] and phone number +46 8 121 576 90. For more information, please visit

The information was submitted for publication, through the above contact persons, on February 17, 2022 at 10:00 a.m. CET.

This information was brought to you by Cision,c3508396

Show original content:

SOURCE Devyser Diagnostics AB

Company Codes: ISIN: SE0016588867, Stockholm: DVYSR

Source link


Comments are closed.